A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a phase 3, open-label, multiple-center, randomized cross-over study to assess the safety and efficacy of \[123I\]NAV5001 SPECT imaging in aiding in the differentiaion of parkinsonian syndromes from non-parkinsonian tremor.
Epistemonikos ID: 537a712744f16d2f6d761db80cedad34235b3fe4
First added on: May 11, 2024